Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Int J Cancer. 2010 May 1;126(9):2112–2122. doi: 10.1002/ijc.24909

Table 1.

Fold change in dopamine receptor subunit expression in cholangiocarcinoma compared to H69 cholangiocyte cells

Receptor Mz-ChA-1 HuCCT-1 SG231 CCLP-1
D1DR 5.43 ± 1.25* 0.66 ± 0.11* 0.85 ± 0.08 0.48 ± 0.05*
D2DR 3.92 ± 0.72* 2.14 ± 0.21* 0.16 ± 0.03* 3.13 ± 0.21*
D3DR 2.87 ± 0.76* 1.01 ± 0.03 0.79 ± 0.03 0.49 ± 0.03*
D4DR 0.38 ± 0.06* 0.49 ± 0.02* 0.27 ± 0.02* 0.76 ± 0.04*
D5DR 2.45 ± 0.71* 0.27 ± 0.03* 0.49 ± 0.05* 0.18 ± 0.02*

● p<0.05 compared to non -malignant cholangiocytes (H69)

● significant increases is shaded in purple, significant decrease are shaded in gray, no shading indicates no significance.